Showing results (1451-1460 of 1,591) with videos related to

Sort By:
Pageof 160
Experimental & Molecular Medicine|June 10, 2021
The clinical use of blood-test factors for Alzheimer's disease: improving the prediction of cerebral amyloid deposition by the QPLEXTM Alz plus assay kitHaeng Jun Kim, Jong-Chan Park, Keum Sim Jung, et al.
NPJ Vaccines|June 29, 2023
Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged miceSonia Jangra, Jeffrey J Landers, Gabriel Laghlali, et al.
Alzheimer'S Research & Therapy|March 24, 2017
Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid depositionJong-Chan Park, Sun-Ho Han, Hyun Jin Cho, et al.
Stem Cell Reports|October 9, 2018
Selective Elimination of Culture-Adapted Human Embryonic Stem Cells with BH3 MimeticsSeung-Ju Cho, Keun-Tae Kim, Ho-Chang Jeong, et al.
Traffic Injury Prevention|March 28, 2018
Injury analysis of patients according to impact patterns involved in pedestrian traffic crashesHee Young Lee, Hyun Youk, Jeong Ii Lee, et al.
Chemical Science|June 14, 2021
Synthetic biohybrid peptidoglycan oligomers enable pan-bacteria-specific labeling and imaging: in vitro and in vivoJing-Xi He, Kim Le Mai Hoang, Shu Hui Kho, et al.
Annals of Coloproctology|April 27, 2023
Stratification of rate of lymph node metastasis according to risk factors and oncologic outcomes in patients who underwent radical resection for rectal neuroendocrine tumorsMyung Jae Jin, Sung Sil Park, Dong-Eun Lee, et al.
Journal of Breast Cancer|December 30, 2017
The Practice Patterns and Perceptions of Korean Surgeons Regarding Margin Status after Breast-Conserving SurgeryTae-Kyung Yoo, Sung-Won Kim, Eunyoung Kang, et al.
International Journal of Rheumatic Diseases|July 12, 2021
Clinical characteristics of non-radiographic axial spondyloarthritis: Results of the Korean Nonradiographic Axial SPondyloArthritis (KONASPA) dataHyemin Jeong, Yong-Gil Kim, Tae-Hwan Kim, et al.
Experimental Cell Research|June 27, 2015
Pyruvate kinase isoenzyme M2 is a therapeutic target of gemcitabine-resistant pancreatic cancer cellsDong Joon Kim, Young Soo Park, Min Gu Kang, et al.
Pageof 160